Lung Yeh Cho

KPMG Taiwan Inc. provides financial advisory services. The private company is based in Taipei, Taiwan. The Taiwanese company was founded by Kuo Feng Wu, Pao Kuei Chu. The CEO is Kwo-Juh Maa.

Diamond BioFund Inc (Diamond BioFund) is an independent venture capital firm founded in 2013 by Microbio Group, Fubon Financial, Taishin Holdings and Ruentex Group. The firm is headquartered in Taipei, Taiwan.

RenBio, Inc. is a preclinical biotechnology company based in New York, NY. The company is focused on developing novel antiviral antibody therapeutics and a next-generation antibody delivery platform. RenBio's lead compound, rb-100, is a SARS-CoV-2 bispecific antibody that has demonstrated robust antiviral activity against emerging and evolving SARS-CoV-2 variants. The company is also developing a revolutionary, next-generation nucleic acid-based antibody delivery platform called Myo (Make Your Own) Technology™. RenBio was co-founded by David D. Ho, a world-renowned HIV expert and founding scientific director of the Aaron Diamond AIDS Research Center, and Yaoxing Huang, an associate professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons. The company has received non-dilutive financing from the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, and MedImmune (now AstraZeneca).